QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT04898543 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04898543
- Sponsor
- ImmunityBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-21
- Primary completion
- 2026-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.